Quantexa has appointed three industry luminaries, including Ralph Schlosstein, Matthew Gould, and Sir Jeremy Fleming, to its Advisory Board. This move follows a $129 million Series E funding round, positioning Quantexa as a unicorn in the UK tech industry. The company plans to invest over $155 million in the global AI industry over the next three years.
Facts
- Ralph Schlosstein, former CEO of Evercore and former President of BlackRock, joins Quantexa’s Advisory Board, bringing extensive experience in investment banking.
- Matthew Gould, former CEO of NHSX and British ambassador to Israel, will provide expertise in healthcare and data-driven decision-making.
- Sir Jeremy Fleming, Former Director of GCHQ and Deputy Head of MI5, brings over 30 years of intelligence and technology experience.
- Vishal Marria, CEO of Quantexa, welcomes the new Advisory Board members, emphasizing their expertise in finance, healthcare, and national security.
- Quantexa plans to continue developing decision intelligence solutions and accelerate growth strategies in the emerging Decision Intelligence category.
- Ralph Schlosstein expresses confidence in Quantexa’s potential to capture opportunities in Decision Intelligence.
- Matthew Gould highlights Quantexa’s innovative approach to data utilization.
- Sir Jeremy Fleming looks forward to combining his experience with Quantexa’s capabilities to enhance data-driven decision-making.
- With the Advisory Board’s support, Quantexa aims to empower organizations to make trusted operational decisions through Decision Intelligence solutions.
